Amount raised
€58M
€58,181,818
Native amount
64,000,000 USD
Stage
Series B
series b
Investors
8
Provenance & confidence
UnverifiedAmount
64,000,000 USD
ECB-at-date → €59M · rate 1.0759 on 2015-03-31
stored → €58M
High confidence
Source
No source on record — unverified.
Unverified
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
8Abingworth LLPBayer Global InvestmentsCelgeneGlaxoSmithKlineNew Enterprise AssociatesSR OneVersant VenturesVertex Ventures
Date
Mar 2015
Round type
series b
Amount (EUR)
€58M